Breaking
ESC Congress Unveils Pivotal Cardiovascular Trial Data, Reshaping Treatment Paradigms and Market Dynamics
Breakthrough Monoclonal Antibody Targeting SFRP2 Protein Offers New Hope for Combating Triple-Negative Breast Cancer and Treatment Resistance
Harnessing Vitamin K Analogues: A Novel Frontier in Combating Neurodegenerative Diseases
University of South Australia Research Reveals Contraceptive Pill and Childbearing Significantly Reduce Ovarian Cancer Risk Through AI-Driven Study
CureSearch for Children’s Cancer Appoints Fisher Phillips Chairman John Polson to Board of Directors
Karolinska Institutet Researchers Unveil Age-Dependent Immune Responses in Childhood Cancer, Charting Course for Precision Immunotherapy
Spermidine Supplementation Shows Promise in Enhancing Vaccine Responses in Older Adults by Mitigating Immune System Aging
COVID-19 mRNA Vaccination Linked to Significant Survival Gains in Advanced Lung and Skin Cancer Patients Undergoing Immunotherapy
Targeting potassium channel shows promise for treating brain tumors
A Novel Nanotechnology Approach Revolutionizes Chemotherapy Drug Delivery and Efficacy
2 Sep 2026, Wed

women’s health

You Missed

Biotech, Pharma & Cancer Drug Development

ESC Congress Unveils Pivotal Cardiovascular Trial Data, Reshaping Treatment Paradigms and Market Dynamics

Genitourinary, Prostate & Kidney Cancer

Breakthrough Monoclonal Antibody Targeting SFRP2 Protein Offers New Hope for Combating Triple-Negative Breast Cancer and Treatment Resistance

Hematology, Leukemia & Lymphoma

Harnessing Vitamin K Analogues: A Novel Frontier in Combating Neurodegenerative Diseases

Gynecologic Oncology (Ovarian, Cervical)

University of South Australia Research Reveals Contraceptive Pill and Childbearing Significantly Reduce Ovarian Cancer Risk Through AI-Driven Study